XtalPi Introduces AI-Powered XGlue Platform for Molecular Glue Drug Discovery
XtalPi unveiled its AI-driven XGlue platform at the 2026 International Symposium on Molecular Glue Drug Discovery in Shanghai, announced in a press release. The event gathered scientists, biopharma innovators, and investors to discuss advances in targeting previously undruggable proteins.
XGlue integrates physics-based AI modeling with an autonomous synthesis workflow to form a closed-loop design–make–test system. This setup allows rapid iteration and expands the range of potential targets for molecular glue therapeutics.
Speakers from institutions including Stanford University, EPFL, and the Chinese Academy of Sciences presented research on computational design and rational discovery of molecular glues for diseases with unmet medical needs. Industry participants from companies such as Sanofi and Betta Pharma joined discussions on improving collaboration between academic research, industrial development, and clinical applications.
The symposium concluded with consensus on the importance of integrating AI, robotics, and cross-sector partnerships to advance protein degradation and accelerate the translation of molecular glue therapies into clinical use.
We hope you enjoyed this article
Consider subscribing to one of our newsletters like Life AI Weekly or Daily AI Brief.
Also, consider following us on social media:
More from Life Sciences
Oct 16 Study Tests Smartphone AI for Children's Lung Sounds Oct 16 Manhattan Physician Invests in RunPractice Oct 16 Attilio appoints Buck Institute CEO Eric Verdin as cochairman Oct 16 Aignostics launches HETA Clinical for pathology workflows Oct 16 Specialty1 Partners Invests in AI for Dental Practice OperationsLife AI Weekly
Weekly coverage of AI applications in healthcare, drug development, biotechnology research, and genomics breakthroughs.
Whitepaper
Tensordyne Napier: What If One Rack Could Do the Work of Nine?
Tensordyne
This Tensordyne whitepaper presents Napier, an inference-focused AI processor and rack-scale system based on the company’s TDN Math logarithmic number system. It examines infrastructure requirements for large mixture-of-experts and agentic models, compares major inference architecture approaches, and details the TDN AIP processor, TDN72 pod, TDN Link fabric, and Napier Ultra configuration. The paper reports simulation-based performance, cost, and accuracy-validation results, including Tensordyne’s projected comparison of one Napier rack with a nine-rack Nvidia Rubin plus Groq deployment; the chip is reported as taped out and in fabrication.
Read moreYou may also like
XtalPi Advances Hair Loss Drug Into IND Enabling Studies
Xtalks Plans Webinar on AI for Antibody Process Optimization
INmune Bio and QCi Apply Quantum Computing to XPro Research
XtalPi and Fangda Carbon Deploy AI for Graphite Electrode Production
Tsingke Introduces Validation Workflow for AI Designed Proteins
Daily AI Brief: the AI news that matters, in your inbox.